While many studies have analyzed the impact of APOE4 on all-cause mortality25–28, ours is the first to thoroughly investigate the heterogeneous associations and opposing effects of APOE4 on two competing types of mortality risk by accounting for the low versus high amounts of autopsy-assessed AD neuropathology in the brain at death. This evidence concerns the gene APOE and Alzheimer disease.